• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[手术治疗——Ⅰ-Ⅱ期卵巢癌患者的预后因素]

[Operative treatment--prognostic factor in patients with ovarian cancer stage I-II].

作者信息

Lazarov N, Lazarov L, Lazarov S

出版信息

Akush Ginekol (Sofiia). 2013;52(2):13-6.

PMID:23807975
Abstract

OBJECTIVE

The authors present and analyze the modern concepts of the role of surgery as a prognostic factor for patients with early epithelial ovarian cancer (st. I-II). They review, synthetize and summarize the information from 15 studies, published in the recent years, and concerning the subject.

CONCLUSION

Surgery treatment for early epithelial ovarian cancer is one of the most important prognostic factors. The appropriate surgical performance contributes either for complete staging or for optimal primary cytoreduction and strongly influence the development and outcome of disease.

摘要

目的

作者阐述并分析了手术作为早期上皮性卵巢癌(I-II期)患者预后因素的现代概念。他们回顾、综合并总结了近年来发表的15项关于该主题的研究信息。

结论

早期上皮性卵巢癌的手术治疗是最重要的预后因素之一。恰当的手术操作有助于实现全面分期或达到最佳的初次肿瘤细胞减灭,对疾病的发展和转归有重大影响。

相似文献

1
[Operative treatment--prognostic factor in patients with ovarian cancer stage I-II].[手术治疗——Ⅰ-Ⅱ期卵巢癌患者的预后因素]
Akush Ginekol (Sofiia). 2013;52(2):13-6.
2
[The role of adjuvant chemotherapy as a prognostic factor in patients with early stage of epithelian ovarian cancer (I - II stage)].
Akush Ginekol (Sofiia). 2013;52(1):58-61.
3
Prognostic value of residual tumor size in patients with epithelial ovarian cancer FIGO stages IIA-IV: analysis of the OVCAD data.上皮性卵巢癌国际妇产科联盟(FIGO)分期 IIA-IV 期患者残余肿瘤大小的预后价值:OVCAD 数据分析。
Int J Gynecol Cancer. 2012 Mar;22(3):380-5. doi: 10.1097/IGC.0b013e31823de6ae.
4
Results of Primary Cytoreductive Surgery in Advanced-stage Epithelial Ovarian Cancer: A Single-center Experience.晚期上皮性卵巢癌初次肿瘤细胞减灭术的结果:单中心经验
Anticancer Res. 2015 Jul;35(7):4099-104.
5
Prognostic significance of thrombocytosis, platelet parameters and aggregation rates in epithelial ovarian cancer.血小板增多症、血小板参数及聚集率在上皮性卵巢癌中的预后意义
J Obstet Gynaecol Res. 2014 Jan;40(1):178-83. doi: 10.1111/jog.12151. Epub 2013 Sep 19.
6
Retrospective analysis of outcomes of secondary debulking surgery for recurrent epithelial ovarian cancer with favorable prognostic factors.对具有有利预后因素的复发性上皮性卵巢癌二次肿瘤细胞减灭术的结局进行回顾性分析。
J Obstet Gynaecol Res. 2014 Mar;40(3):791-6. doi: 10.1111/jog.12222. Epub 2013 Nov 18.
7
Introduction of staging laparoscopy in the management of advanced epithelial ovarian, tubal and peritoneal cancer: impact on prognosis in a single institution experience.分期腹腔镜检查在晚期上皮性卵巢癌、输卵管癌和腹膜癌治疗中的应用:单中心经验对预后的影响。
Gynecol Oncol. 2013 Nov;131(2):341-6. doi: 10.1016/j.ygyno.2013.08.005. Epub 2013 Aug 9.
8
Preoperative serum CA125 levels do not predict suboptimal cytoreductive surgery in epithelial ovarian cancer.术前血清CA125水平不能预测上皮性卵巢癌的减瘤手术效果欠佳。
Int J Gynecol Cancer. 2008 Jul-Aug;18(4):621-8. doi: 10.1111/j.1525-1438.2007.01064.x. Epub 2007 Sep 14.
9
Surgical and survival outcomes of laparoscopic staging surgery for patients with stage I ovarian cancer.I期卵巢癌患者腹腔镜分期手术的手术及生存结局
Taiwan J Obstet Gynecol. 2018 Feb;57(1):7-12. doi: 10.1016/j.tjog.2017.12.002.
10
Prognostic factors for maximally or optimally cytoreduced stage III nonserous epithelial ovarian carcinoma treated with carboplatin/paclitaxel chemotherapy.接受卡铂/紫杉醇化疗的最大程度或最佳细胞减灭术的 III 期非浆液性上皮性卵巢癌的预后因素。
J Obstet Gynaecol Res. 2018 Jul;44(7):1284-1293. doi: 10.1111/jog.13663. Epub 2018 May 4.